Upsher Pays $553M to Swallow Proximagen Up - June 13, 2012

Having trouble viewing this email? View in Browser.

Wednesday, June 13, 2012  |   |   |   |  Pharm-Olam has offices among the most populated cities in Europe, Latin America, India, South Africa, and the USA to provide cost effective coverage for oncology studies of all sizes. Pharm-Olam has helped bring 2 oncology compounds to NDA approval and have conducted oncology studies in over 30 countries. The majority of our clinical staff are MDs or PhDs, including oncologists in strategic areas for clinical trials. The incidence of oncology indications and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0- 1344 891121   •  Upsher-Smith Laboratories Pays $553 Million to Swallow Proximagen Group plc. Up More... •  Rhythm Drums Up $25 Million to Advance Diabetes and Obesity Drugs More... •  New Firm Select BioVentures Seeks $200 Million for Biotech Deals in Sunshine State More... •  Newron Pharmaceuticals (NWRN) Snags NeuroNova AB for About $19.3 Million in Shares for Clinical ALS and Parkinson Disease Drugs More... •  Merck & Co., Inc. (MRK) Sleep Drug Reduced Insomnia in Study More... •  Astex Pharmaceuticals (ASTX) Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor More... •  CVS Caremark Corporation (CVS), Rite Aid Sue Pfizer Inc. (PFE) Over Depression Drug More... •  Are Things Finally Looking Up for Johnson & Johnson (JNJ)? More... More Top News 3D Cell Culture Made Easy. NEW! 96-Well Perfecta3D® Hanging Drop Plate! Pre-order your Case of 8 96-Well Perfecta3D Hanging Drop Plates today! http://3dbiomatrix.com/products/?type=email&source=tnb-3dbiomatrix-061212 Attending the 2012 BIO International Convention? Stop by Booth #0701 to preview the plates and find out more! •  Dental Plaque Hikes Cancer Risk, BMJ Reveals More... •  Exercise Pill: Scientists Find Compound That May Make You Want to Hit the Gym, University of Zurich Study More... •  In One Type of Cancer, Heavier Men May Live Longer, Washington University School of Medicine Study More... •  Alzheimer's-Linked Gene May Have More Effect on Women, Stanford University School of Medicine Study More... •  Mutated Gene May Trigger Prostate Cancer, University of California, Davis (UCD) Study More... •  Heavy Drinking, Smoking Won't Harm Men's Sperm, Mount Sinai Hospital Study More... •  Fish Oils "Don't Help Ward Off Dementia," London School of Hygiene and Tropical Medicine Reveals More... •  Father's Love Shapes a Child's Personality, University of Connecticut Study More...   More Featured News BioContact Quebec October 3 - 4, 2012 Chateau Laurier Quebec 1220 Place Biopharmaceutical partnership symposium that is expecting more than 500 participants representing all sectors of the industry. namely biopharmaceutical and pharmaceutical companies, universities, venture capital, consulting and governmental organizations. For more information, please visit: www.biocontact.ca. • Biotech Bay (Menlo Park, California) Geron Corporation Senior Research Associate, Translational Research Will provide research support for Geron's first-in-class cancer therapeutics currently in clinical trials. Assist in designing and executing in vitro experiments involving tumor cell lines and primary cells from diseased patients. Perform colony-forming assays and maintain long-term hematopoietic cell cultures. • Genetown (Boston, Massachusetts) HireMinds LLC Project Manager Will lead customer implementations following the sale - from the initial project kickoff through launch and beyond. We are looking for candidates who are experienced and preferably certified project managers. • Pharm Country (Wayne, Pennsylvania) Shire Pharmacoeipdemiology Director Provides essential specialist guidance and direction to project teams, senior leaders, and other colleagues to ensure optimal management of high-impact project opportunities and risks, to ensure scientific quality and timely, cost-effective project delivery while adhering to ethical requirements and responding to business needs. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Strategic Sourcing Lead Leads strategic sourcing for a broad group of categories with a goal obtaining the highest quality goods and services at optimal cost to Takeda. Operates as a key strategic sourcing resource in the Purchasing Department helping to shape budget plans and deliver to savings goals. • BioCapital (Gaithersburg, Maryland) Sequenom Inc. Laboratory Associate Under supervision of licensed personnel, the Laboratory Associate will assist with routine and specialty clinical testing and provide general support for the laboratory. Perform basic molecular processes associated with laboratory tests such as DNA extraction, PCR, and genomic library preparation under the supervision of certified laboratory personnel. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 BIO Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Massachusetts region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • 2012 BIO Career Fair, Boston, MA June 18, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Stem Cell Market Outlook • Identify potential growth markets with sales forecasts by indication and expected timing of market entry. • Compare the different business models for stem cell therapies. • Evaluate which novel products offer the greatest potential clinical advances over the next several years and why. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Operon Biotechnologies, Inc. 2211 Seminole Drive Huntsville, Alabama 35805 U.S.A. Phone: 800-688-2248 Operon Biotechnologies, Inc. is the global market leader in high throughout synthesis and provider of a wide range of quality DNA oligonucleotides, array-ready oligo sets (AROS™) and preprinted slides (OpARRAY™). Driven by incomparable customer service and reliable delivery, Operon employs advanced synthesis technologies and support. More Company Profiles FREE Subscription to Lab Manager Magazine® Lab Manager Magazine® helps provide a forum and a framework to help lab professionals hire and supervise staff, establish a laboratory, and plan a coherent research program, while keeping the goals of good science and scientific discovery at the forefront. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.